Comprehensive Characterization of the Multiple Myeloma Immune Microenvironment Using Integrated scRNA-seq, CyTOF, and CITE-seq Analysis

Concordance Mass cytometry
DOI: 10.1158/2767-9764.crc-22-0022 Publication Date: 2022-08-31T13:51:44Z
ABSTRACT
As part of the Multiple Myeloma Research Foundation (MMRF) immune atlas pilot project, we compared cells multiple myeloma bone marrow samples from 18 patients assessed by single-cell RNA sequencing (scRNA-seq), mass cytometry (CyTOF), and cellular indexing transcriptomes epitopes (CITE-seq) to understand concordance measurements among techniques. Cell type abundances are relatively consistent across three approaches, while variations observed in T cells, macrophages, monocytes. Concordance correlation analysis cell marker gene expression different modalities highlighted importance choosing genes best suited particular modalities. By integrating data these assays, found International Staging System stage 3 exhibited decreased CD4+ T/CD8+ ratio. Moreover, upregulation RAC2 PSMB9, natural killer fast progressors with those nonprogressors, as revealed both scRNA-seq CITE-seq measurement. This detailed examination microenvironment using technologies markers associated rapid progression which will be further characterized full-scale project. Significance: scRNA-seq, CyTOF, increasingly used for evaluating heterogeneity. Understanding their concordances is great interest. To date, this study most comprehensive measurement identified predicted significantly progression.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (25)
CITATIONS (20)